Search PubMed⌕ Search

Biomedical subjects

J W Funder

Publications and source records attributed to J W Funder.

At least 271 records · Page 15Linked to original sources

Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin.

The abnormal high capacity T4 binding site of familial euthyroid T4 excess was separable from prealbumin and T4-binding globulin but not from albumin. We therefore compared T4 binding by albumin preparations isolated from the sera of normal and affected subjects. By equilibrium dialysis, albumin from affected subjects showed an extra T4 binding site (Kd approximately 50 nM) in addition to the T4 binding sites of normal albumin (Kd approximately 4 microM). Comparison of the estimated capacity of the additional site (200 microM) with the molar concentration of albumin suggested that only about one third of albumin molecules from affected subjects contained the extra binding site. Estimates of affinity and capacity were used to derive combining powers for the diverse classes of serum T4 binding sites. From these estimates, it appears that the presence of the abnormal site accounts for the approximate doubling of normal mean total T4 (from approximately 100 nM or 7.7 micrograms/dl to approximately 200 nM or 15.5 micrograms/dl), in order to maintain a normal free T4 in the face of the increased T4 association with albumin. Studies of [125I]T4 displacement from albumin of affected subjects showed low T3 affinity and competition by barbitone. Relative molar concentrations to give equivalent displacement of [125I]T4 were: 3,3',5,5'-tetraiodothyroacetic acid, 0.4; T4, 1.0; rT3, 4; 8-anilinonaphthalene sulfonic acid, 10; T3, 80; salicylate, 200; and barbitone, 40,000. Studies with dithiothreitol suggested that disulfide bonds were critical in maintaining the T4-albumin association. These findings indicate that familial T4 excess is due to abnormal intermediate affinity, sulfhydryl-sensitive T4 binding sites that are inseparable from the albumin found in affected subjects.

Barbital↗

Panax ginseng and Eleuthrococcus senticosus extracts--in vitro studies on binding to steroid receptors.

We have examined the binding of 44% saponin from Panax ginseng, and extracts from Eluthrococcus senticosus (Siberian ginseng) to classical steroid receptors in vitro. Both extracts had demonstrable affinity for progestin, mineralocorticoid and glucocorticoid receptors; the Siberian ginseng also bound to estrogen receptors. Highest affinity binding was to glucocorticoid receptors, with an approximate Ki of 8 x 10(-6) M for Panax ginseng. Such interactions may explain the reported glucocorticoid-like effects of ginseng in vivo.

Animals↗

Relationship between pituitary nuclear oestrogen receptors and the release of LH, FSH and prolactin in the ewe.

Ovariectomized ewes were given a single injection (i.v.) of 100 micrograms oestradiol-17 beta. Nuclear oestrogen receptor values in the pituitary, as a function of total receptor concentrations, were 3.0 +/- 1.0% in controls, 56.0 +/- 5.4% at 1 h (P less than 0.001) and 6.5 +/- 2.1% at 6 h (P less than 0.05) after oestradiol injection. There was a fall in plasma LH values from 5.7 +/- 1.0 (preinjection) to 2.1 +/- 0.3 ng/ml (P less than 0.01) 4-6 h after oestradiol. At 13-21 h after injection plasma levels increased to 37 +/- 8 ng/ml (P less than 0.001). Plasma FSH levels declined from 840 +/- 18 to 506 +/- 48 ng/ml after 20-22 h (P less than 0.001). Plasma prolactin concentrations fell from 90 +/- 16 ng/ml before injection to 29 +/- 9 ng/ml at 1 h (P less than 0.05), and then rose to a maximum of nuclear compartmentalization of oestrogen receptors after a bolus injection of oestradiol was associated with the feedback effects of oestradiol on LH, FSH and prolactin release.

Animals↗

Effects of 2-hydroxyoestradiol-17 beta on plasma luteinizing hormone, follicle-stimulating hormone and prolactin, and nuclear translocation of pituitary oestrogen receptors in ovariectomized ewes.

The ability of oestradiol-17 beta (OE2) and 2-hydroxyoestradiol (2OH-OE2) to translocate pituitary oestrogen receptors to the nuclear compartment and to affect plasma concentrations of LH, FSH and prolactin was studied in ovariectomized ewes. Mean (+/- S.E.M.) nuclear oestrogen receptor levels (% of total pituitary oestrogen receptors) after intracarotid injections of 1.25 micrograms OE2, 400 micrograms 2OH-OE2 or vehicle were 8.7 +/- 2.3, 16.9 +/- 3.2 and 0.8 +/- 0.1% respectively. Whereas 1.25 or 12.5 micrograms OE2 significantly lowered plasma LH and FSH, 400 micrograms 2OH-OE2 did not affect plasma LH or FSH levels. Injection of 4000 micrograms 2OH-OE2 however, significantly affected plasma LH and FSH. Plasma prolactin levels were not significantly affected by the treatments. These data indicate a discrepancy between oestrogen receptor occupancy and effects on gonadotrophin and prolactin secretion after injection of catechol oestrogen.

Animals↗

Glucocorticoid induction of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo.

1. Endothelial cells from bovine aortae, grown to confluence in culture and then maintained for 2 days in serum-free medium produced an enzyme which closely resembled angiotensin converting enzyme (ACE). 2. Dexamethasone increased cell ACE activity 6- to 7-fold with a threshold near 0.3 nmol/l. This effect was completely inhibited by actinomycin D or cycloheximide. 3. Deoxycorticosterone (DOC) and aldosterone were approximately 0.1% as active as dexamethasone. 4. In cells incubated in the presence of dexamethasone (10 nmol/l), DOC (10 mumol/l) inhibited ACE production suggesting that DOC is a partial glucocorticoid agonist/antagonist in this system. 5. Adrenalectomized rats had lower pulmonary ACE compared to intact controls. This was restored by injections of dexamethasone (40 micrograms/day) but not by DOC (40 micrograms/day) or aldosterone (10 micrograms/day). The dose response curve for dexamethasone induction of pulmonary ACE mirrored that for thymolysis; for both, half maximal effects were seen at approximately equal to 6 micrograms/day and plateau levels at approximately equal to 60 micrograms/day. 6. Glucocorticoids appear to be potent inducers of ACE activity in endothelial cells in culture and rat lung in vivo. The action of DOC and aldosterone probably reflects occupancy of glucocorticoid receptors. This effect may be of significance in modulating ACE in local vascular beds.

Animals↗

Dihydrotestosterone and estradiol deplete corticosensitive thymocytes lacking in receptors for these hormones.

The sex steroids dihydrotestosterone (DHT) and estradiol (E2), were found to deplete the same cortical population of thymocytes as the glucocorticoid dexamethasone (DM) in intact and in adrenalectomized, castrated mice. Although receptors for DM were demonstrated in this cortical population, none were found for E2 or DHT. We suggest that the sex steroids bind to other thymic elements, possibly thymic reticular epithelial cells, which may in turn act secondarily on cortical thymocytes, or their precursors within the thymus.

Animals↗

Effects of bromocriptine on blood pressure and plasma beta-endorphin in spontaneously hypertensive rats.

1. Immunoreactive beta-endorphin (IR-beta EP) was two- to three-fold higher in pituitary neuro-intermediate lobes (N-IL) of spontaneously hypertensive rats (SHR) than of normotensive Wistar--Kyoto (NT-WKY) controls. 2. Plasma levels of IR-beta EP were lower in SHR than in NT-WKY rats. 3. Intravenous injections of morphine lowered blood pressure of both SHR and NT-WKY rats to the same level; naloxone restored blood pressure of both groups to pre-morphine values. 4. Infusion of bromocriptine in SHR for 1 week lowered blood pressure and N-IL IR-beta EP concentration. 5. These results confirm and extend postulated dopaminergic defect in this model of hypertension.

Animals↗

Naloxone, adrenalectomy, and steroid replacement: evidence against a role for circulating beta-endorphin in food intake.

Naloxone has a dose-dependent, significant anorectic effect when administered to normal rats, consistent with an antagonism of central or peripheral enkephalinergic or endorphinergic mechanisms. Mean levels of circulating immunoreactive beta-endorphin were similar in intact rats (0.5 ng/ml) and dexamethasone-treated adrenalectomized rats (0.5 ng/ml). In contrast, plasma levels were high in adrenalectomized rats with no replacement steroid (1.3 ng/ml) and in adrenalectomized rats given the mineralocorticoid deoxycorticosterone (0.9 ng/ml). In sharp distinction to the clear changes in circulating immunoreactive beta-endorphin produced by adrenalectomy and selective steroid replacement, no differences were seen in baseline food intake or anorectic response to naloxone. We conclude that a physiological role for circulating beta-endorphin in the regulation of food intake appears unlikely.

Adrenal Cortex Hormones↗

Orally active mineralocorticoid agonists and antagonists: delta 1-derivatives of aldosterone and 18-deoxyaldosterone.

The effect of delta 1 unsaturation on the oral effectiveness of a representative mineralocorticoid agonist and antagonist was investigated in an adrenalectomized rat bioassay. Dehydrogenation at the 1.2 position did not alter the qualitative nature of the mineralocorticoid activity of the parent compound. Thus delta 1-aldosterone (21,18-dihydroxy-11 beta, 18-oxido-1,4-pregnadiene-3,20-dione) retained pure mineralocorticoid agonism, and delta 1-18-deoxyaldosterone (21-hydroxy-11 beta, 18-oxido-1,4-pregnadiene-3,20-dione)demonstrated the same relative degree of predominant antagonism as 18-deoxyaldosterone (21-hydroxy-11 beta, 18-oxido-4-=pregnene-3,20-dione) itself. In each instance, receptor affinity was diminished by 1,2 unsaturation, but this effect was offset by the greater bioavailability of the delta 1 derivatives on oral administration. (Endocrinology 108: 517, 1981)

Administration, Oral↗

19-Nor progesterone is a mineralocorticoid agonist.

19-Nor progesterone (19-nor P) has previously been shown to have a approximately 3-fold higher affinity for mineralocorticoid receptors than progesterone (P), its C-19 methylated parent steroid; in contrast, 19-nor aldosterone has less than 1% the mineralocorticoid receptor affinity of aldosterone. In the present study we have compared P and 19-nor P, in terms of their mineralocorticoid activity in an adrenalectomized rat urinary K+/Na+ bioassay system. Progesterone, as previously has been shown, is a mineralocorticoid antagonist with no agonist activity. In contrast, 19-nor progesterone is a full mineralocorticoid agonist, with no discernible antagonist activity. Loss of the C19 methyl is thus followed by profound changes in mineralocorticoid activity (aldosterone: agonist to inactive; progesterone: antagonist to agonist). In the light of the recent demonstration of C19 demethylation by the kidney, such changes in mineralocorticoid activity may be implicated in currently unexplained syndromes of sodium retention.

Adrenalectomy↗

Androgens and the thymus.

Tritiated dihydrotestosterone ([3H]DHT) binds with high affinity to a single class of limited capacity sites in cytoplasmic preparations from rat and mouse thymus glands. The affinity of these bindings sites for [3H]DHT (Kd at 4 C, 1 nM) and their specificity [methyltrienolone (R1881) greater than DHT greater than testosterone much greater than estradiol = progesterone greater than promegesterone (R5020) much greater than aldosterone = cortisol] are characteristic of androgen receptors in classical target tissues. The affinity of thymic androgen receptors for [3H]DHT did not differ with age, sex, or species; the concentration of androgen receptors was higher in males than females and higher in older compared with younger animals. Castration of male mice was followed by marked (approximately 2-fold) thymic hypertrophy; the concentration of androgen receptors fell to approximately one third the control value as a function of organ weight, but did not change significantly as a function of thymic DNA. Chronic administration of DHT (200 micrograms/day) did not alter thymic weight or androgen receptor levels in intact male mice. In castrate mice, however, the administration of 200 micrograms DHT completely abolished the thymic hypertrophy otherwise seen post castration and significantly increased the total thymic content of androgen receptor. The administration of dexamethasone (0.6-60 micrograms/day for 5 days) caused dose-related thymolysis; on a weight basis, the concentration of androgen receptor rose markedly, suggesting that androgen receptors are confined to the subpopulation of thymocytes relatively resistant to glucocorticoids.

Aging↗

Mineralocorticoid receptors in rat anterior pituitary: toward a redefinition of "mineralocorticoid hormone".

There is increasing evidence that a pituitary factor(s) in addition to ACTH can influence aldosterone secretion. By analogy with glucocorticoids and ACTH, such a factor(s) may be under mineralocorticoid negative feedback control, presumably via specific mineralocorticoid receptors. We here report studies in which mineralocorticoid receptors in the anterior pituitary are described and clearly distinguished from glucocorticoid receptors. Pituitary mineralocorticoid receptors closely resemble those previously reported in rat kidney and salivary gland in terms of their affinity for aldosterone, the hierarchy of affinities they display for other steroids, and their sedimentation values on sucrose density gradients.

Aldosterone↗

Mineralocorticoid receptors in the rat lung.

In lung cytosol from adrenalectomized rats, tritiated aldosterone binds to two classes of limited capacity sites with affinities (Kd at 37 C) of 0.7 and 80 nM. The predominant binding species sediments at approximately 9S on sucrose density gradients in low ionic strength, molybdate-containing buffer. Binding of tritiated aldosterone (5 nM) is displaced by a 4-fold excess of nonradioactive hormone in the following hierarchy: 9 alpha-fluorocortisol greater than aldosterone greater than deoxycorticosterone much greater than corticosterone greater than dexamethasone. Thus, pulmonary tissue contains steroid-binding sites with affinity and specificity characteristics equivalent to those previously shown for mineralocorticoid receptors in classic target tissues. The pulmonary cell type(s) in which these putative mineralocorticoid receptors are located and possible physiological roles for mineralocorticoids in adult and fetal lung remain to be explored.

Adrenalectomy↗